EARNINGS PER SHARE

The following tables show the computation of basic and diluted (loss) earnings per common share for each period presented (in thousands, except per share amounts):



	Three Months Ended					Six Months Ended
	July 29, 2017			July 30, 2016		July 29, 2017			July 30, 2016
Basic:
Net (loss) income	$	(6,258	)	$	41	$	(25,245	)	$	(15,419	)
Less: Allocation of earnings to participating securities	(51		)	—		(202		)	—
Net (loss) income allocated to common shares	(6,309		)	41		(25,447		)	(15,419		)

Basic weighted average shares outstanding	27,535			27,111		27,401			27,021
Basic (loss) earnings per share	$	(0.23	)	$	—	$	(0.93	)	$	(0.57	)

	Three Months Ended					Six Months Ended
	July 29, 2017			July 30, 2016		July 29, 2017			July 30, 2016
Diluted:
Net (loss) income	$	(6,258	)	$	41	$	(25,245	)	$	(15,419	)
Less: Allocation of earnings to participating securities	(51		)	—		(202		)	—
Net (loss) income allocated to common shares	(6,309		)	41		(25,447		)	(15,419		)

Basic weighted average shares outstanding	27,535			27,111		27,401			27,021
Add: Dilutive effect of stock awards	—			64		—			—
Diluted weighted average shares outstanding	27,535			27,175		27,401			27,021
Diluted (loss) earnings per share	$	(0.23	)	$	—	$	(0.93	)	$	(0.57	)

The number of shares attributable to SARs and non-vested stock grants that would have been considered dilutive securities, but were excluded from the calculation of diluted loss per common share because the effect was anti-dilutive were as follows (in thousands):



	Three Months Ended		Six Months Ended
	July 29, 2017	July 30, 2016	July 29, 2017	July 30, 2016
Number of anti-dilutive shares due to net loss for the period	—	—	—	53
Number of anti-dilutive SARs due to exercise price greater than average market price of our common stock	119	194	138	203